Fluorescent Sentinel Lymph Node Identification in Colon Carcinoma Using Submucosal Bevacizumab-800CW.

NCT05498051 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
5
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Meander Medical Center